257 related articles for article (PubMed ID: 26785911)
1. Smooth Muscle Precursor Cells Derived from Human Pluripotent Stem Cells for Treatment of Stress Urinary Incontinence.
Wang Z; Wen Y; Li YH; Wei Y; Green M; Wani P; Zhang P; Pera RR; Chen B
Stem Cells Dev; 2016 Mar; 25(6):453-61. PubMed ID: 26785911
[TBL] [Abstract][Full Text] [Related]
2. Smooth Muscle Progenitor Cells Derived From Human Pluripotent Stem Cells Induce Histologic Changes in Injured Urethral Sphincter.
Li Y; Wen Y; Wang Z; Wei Y; Wani P; Green M; Swaminathan G; Ramamurthi A; Pera RR; Chen B
Stem Cells Transl Med; 2016 Dec; 5(12):1719-1729. PubMed ID: 27460854
[TBL] [Abstract][Full Text] [Related]
3. Secretomes of human pluripotent stem cell-derived smooth muscle cell progenitors upregulate extracellular matrix metabolism in the lower urinary tract and vagina.
Zhuang G; Wen Y; Briggs M; Shao Q; Tran D; Wang H; Chen B
Stem Cell Res Ther; 2021 Apr; 12(1):228. PubMed ID: 33823931
[TBL] [Abstract][Full Text] [Related]
4. Do Induced Pluripotent Stem Cell Characteristics Correlate with Efficient In Vitro Smooth Muscle Cell Differentiation? A Comparison of Three Patient-Derived Induced Pluripotent Stem Cell Lines.
Zhou Y; Kang G; Wen Y; Briggs M; Sebastiano V; Pederson R; Chen B
Stem Cells Dev; 2018 Oct; 27(20):1438-1448. PubMed ID: 30153084
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Immuno-Magnetically Sorted Smooth Muscle Progenitor Cells Derived from Human-Induced Pluripotent Stem Cells for Restoring Urethral Sphincter Function.
Li Y; Green M; Wen Y; Wei Y; Wani P; Wang Z; Reijo Pera R; Chen B
Stem Cells Transl Med; 2017 Apr; 6(4):1158-1167. PubMed ID: 28213970
[TBL] [Abstract][Full Text] [Related]
6. Activation of VEGF and ERK1/2 and improvement of urethral function by adipose-derived stem cells in a rat stress urinary incontinence model.
Li GY; Zhou F; Gong YQ; Cui WS; Yuan YM; Song WD; Xin H; Liu T; Li WR; Gao ZZ; Liu J; Guo YL; Xin ZC
Urology; 2012 Oct; 80(4):953.e1-8. PubMed ID: 22950999
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of patient-specific void urine-derived human induced pluripotent stem cells to fibroblasts and skeletal muscle myocytes.
Kibschull M; Nguyen TTN; Chow T; Alarab M; Lye SJ; Rogers I; Shynlova O
Sci Rep; 2023 Mar; 13(1):4746. PubMed ID: 36959367
[TBL] [Abstract][Full Text] [Related]
8. Transplantation of mature adipocyte-derived dedifferentiated fat (DFAT) cells improves urethral sphincter contractility in a rat model.
Obinata D; Matsumoto T; Ikado Y; Sakuma T; Kano K; Fukuda N; Yamaguchi K; Mugishima H; Takahashi S
Int J Urol; 2011 Dec; 18(12):827-34. PubMed ID: 21991997
[TBL] [Abstract][Full Text] [Related]
9. A Functional Comparison of Treatment of Intrinsic Sphincter Deficiency with Muscle-Derived and Adipose Tissue-Derived Stem Cells.
Cui L; Meng Q; Wen J; Gao Z; Yan Z; Tian Y; Xu P; He X; Yu H; Lian P
IUBMB Life; 2018 Oct; 70(10):976-984. PubMed ID: 30212601
[TBL] [Abstract][Full Text] [Related]
10. Autologous bone-marrow-derived mesenchymal stem cell transplantation into injured rat urethral sphincter.
Kinebuchi Y; Aizawa N; Imamura T; Ishizuka O; Igawa Y; Nishizawa O
Int J Urol; 2010 Apr; 17(4):359-68. PubMed ID: 20202003
[TBL] [Abstract][Full Text] [Related]
11. Long-term structural and functional effects of autologous muscle precursor cell therapy in a nonhuman primate model of urinary sphincter deficiency.
Badra S; Andersson KE; Dean A; Mourad S; Williams JK
J Urol; 2013 Nov; 190(5):1938-45. PubMed ID: 23618586
[TBL] [Abstract][Full Text] [Related]
12. Experimental study of therapy of bone marrow mesenchymal stem cells or muscle-like cells/calcium alginate composite gel for the treatment of stress urinary incontinence.
Du XW; Wu HL; Zhu YF; Hu JB; Jin F; Lv RP; Sun S; Wang HY; Xu JW
Neurourol Urodyn; 2013 Mar; 32(3):281-6. PubMed ID: 22847293
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of muscle-derived stem cells plus biodegradable fibrin glue restores the urethral sphincter in a pudendal nerve-transected rat model.
Xu Y; Song YF; Lin ZX
Braz J Med Biol Res; 2010 Nov; 43(11):1076-83. PubMed ID: 21088804
[TBL] [Abstract][Full Text] [Related]
14. Periurethral muscle-derived mononuclear cell injection improves urethral sphincter restoration in rats.
Turco MP; de Souza AB; de Campos Sousa I; Fratini P; Veras MM; Rodrigues MN; de Bessa J; Brolio MP; Leite KRM; Bruschini H; Srougi M; Miglino MA; Gomes CM
Neurourol Urodyn; 2017 Nov; 36(8):2011-2018. PubMed ID: 28346707
[TBL] [Abstract][Full Text] [Related]
15. Periurethral cellular injection: comparison of muscle-derived progenitor cells and fibroblasts with regard to efficacy and tissue contractility in an animal model of stress urinary incontinence.
Kwon D; Kim Y; Pruchnic R; Jankowski R; Usiene I; de Miguel F; Huard J; Chancellor MB
Urology; 2006 Aug; 68(2):449-54. PubMed ID: 16904482
[TBL] [Abstract][Full Text] [Related]
16. The dose-effect safety profile of skeletal muscle precursor cell therapy in a dog model of intrinsic urinary sphincter deficiency.
Williams JK; Eckman D; Dean A; Moradi M; Allickson J; Cline JM; Yoo JJ; Atala A
Stem Cells Transl Med; 2015 Mar; 4(3):286-94. PubMed ID: 25637189
[TBL] [Abstract][Full Text] [Related]
17. Improved sphincter contractility after allogenic muscle-derived progenitor cell injection into the denervated rat urethra.
Cannon TW; Lee JY; Somogyi G; Pruchnic R; Smith CP; Huard J; Chancellor MB
Urology; 2003 Nov; 62(5):958-63. PubMed ID: 14624934
[TBL] [Abstract][Full Text] [Related]
18. Processed lipoaspirate cells for tissue engineering of the lower urinary tract: implications for the treatment of stress urinary incontinence and bladder reconstruction.
Jack GS; Almeida FG; Zhang R; Alfonso ZC; Zuk PA; Rodríguez LV
J Urol; 2005 Nov; 174(5):2041-5. PubMed ID: 16217390
[TBL] [Abstract][Full Text] [Related]
19. Cell Therapy by Mesenchymal Stromal Cells Versus Myoblasts in a Pig Model of Urinary Incontinence.
Knoll J; Amend B; Harland N; Isser S; Bézière N; Kraushaar U; Stenzl A; Aicher WK
Tissue Eng Part A; 2024 Jan; 30(1-2):14-30. PubMed ID: 37933911
[TBL] [Abstract][Full Text] [Related]
20. Urethral injection of dedifferentiated fat cells ameliorates sphincter damage and voiding dysfunction in a rat model of persistence stress urinary incontinence.
Murata Y; Obinata D; Matsumoto T; Ikado Y; Kano K; Fukuda N; Yamaguchi K; Takahashi S
Int Urol Nephrol; 2022 Apr; 54(4):789-797. PubMed ID: 35175498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
